SmithRx
PrivateLast Round
Series C
Jan 19, 2024
Est. Valuation
$100M
Total Funding Raised
$92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SmithRx is a healthcare technology company that operates a pharmacy benefit manager platform designed to enhance transparency, efficiency, and data analytics in managing prescription benefits for employers and their members.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Pharma Supply Chain, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SmithRx Comparables
Compare SmithRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rightway | 84% | |
| EmpiRx Health | 83% | |
| Liviniti | 80% |
SmithRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 19, 2024 | ||||
| Series B | Mar 10, 2022 | ||||
| Series A | Jan 11, 2018 | ||||
| Seed | Mar 31, 2017 |
SmithRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blumberg Capital | Series A |
| Founders Fund | Series B, Series A |
| BoxGroup | Series A |
| Venrock | Series C, Series B |
| NextGen Venture Partners | Series A |
| NextGen Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Job posting indicates Salesforce is a core business system.
- Jun 2, 2026
Mapping identity controls directly to HITRUST framework.
SmithRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SmithRx's valuation, stock price, and market status.
Is SmithRx a public or private company?
SmithRx is a private company.
What is the current stock price of SmithRx?
SmithRx is a private company with no public stock price. No recent secondary market data is available.
How much is SmithRx worth (valuation)?
SmithRx's valuation is estimated at $100.0M based on funding round data.
Can I buy SmithRx stock?
SmithRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SmithRx's last funding round?
SmithRx's most recent funding round was Series C on March 10, 2022.
Who are the main investors in SmithRx?
Key investors in SmithRx include Founders Fund, Venrock.
Will SmithRx IPO soon?
No public IPO plans have been announced for SmithRx.
How can I track SmithRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SmithRx's secondary market activity and sign up for updates.